The weekly litigation news digest is live. Subscribe now

IP Verse

Combination Treatment Of Cancer - EP2785349

The patent EP2785349 was granted to Astrazeneca on Nov 9, 2022. The application was filed on Nov 30, 2012 under application number EP12795842A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2785349

ASTRAZENECA
Application Number
EP12795842A
Filing Date
Nov 30, 2012
Status
Patent Maintained As Amended
Oct 7, 2022
Publication Date
Nov 9, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
TEVA PHARMACEUTICALSJul 14, 2020LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBBADMISSIBLE

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0100172
DESCRIPTIONWO2006124118
DESCRIPTIONWO2009047563
DESCRIPTIONWO2010092371
DESCRIPTIONWO9320097
INTERNATIONAL-SEARCH-REPORTWO2009047563
INTERNATIONAL-SEARCH-REPORTWO2010092371
OPPOSITIONWO2009047563

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents